The Nitrosamines research activities exist under the umbrella of the HESI Genetic Toxicology Technical Committee (GTTC) Mechanism-based Genotoxicity Risk Assessment (MGRA) working group as a “case study” to demonstrate the usefulness of innovative, mechanism-based testing approaches.
This subteam has three goals: (1) to develop a protocol for an optimized Ames assay to predict the carcinogenicity of nitrosamines; (2) identify and verify in vitro assays with metabolically competent cells to support nitrosamines risk identification, and (3) develop a possible in vivo follow-up strategy to verify Ames data within the frame of ICH M7.
View the Nitrosamines webpage here.